STAT Virtual Event | Navigating a New Era in Alzheimer’s Treatment

Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

It took decades for scientists to come up with treatments that could slow the progression of Alzheimer’s disease. Now patients and physicians face a new challenge: actually getting the medicines to people who might benefit from them. Join us for a conversation with a practicing neurologist, neuroscientist and geriatrician about overcoming current hurdles involved in diagnosing, treating, and monitoring patients in a new era for Alzheimer’s disease.

Sponsor Introduction

• Mark Hibberd, M.D., Ph.D., chief medical officer, GE HealthCare Pharmaceutical Diagnostics

Featured Speakers

• Hollis Day, M.D., MS, MHPE, chief, geriatrics; associate professor of medicine, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center
• Jason Karlawish, M.D., professor, Perelman School of Medicine, co-director, Penn Memory Center, University of Pennsylvania
• Lisa M. Renzi-Hammond, Ph.D., Leonard W. Poon Professor for Innovation in Public Health and Aging; director, Institute of Gerontology; co-director, Cognitive Aging Research and Education (CARE) Initiative, College of Public Health at The University of Georgia
• Megan Molteni, science writer, STAT (moderator)

Sponsored By